International Extranodal Lymphoma Study Group (ielsg)

This study is testing a treatment plan for a type of slow-growing cancer called MALT lymphoma. It combines two drugs, chlorambucil and rituximab, given as an initial intensive treatment. Patients who respond then receive rituximab alone as a long-term maintenance therapy for two …

This study is testing whether patients with a type of chest lymphoma need radiation therapy after successful chemotherapy. After standard chemo, patients whose PET scans show no active cancer are randomly assigned to either receive radiation or just be closely monitored. The goal…

This study is testing the safety and effectiveness of combining two existing drugs, ibrutinib and rituximab, for people newly diagnosed with a slow-growing blood cancer called marginal zone lymphoma. The trial will enroll 175 adults who have not yet received any chemotherapy or i…

This trial is testing if a long course of the antibiotic doxycycline can control a rare type of eye lymphoma by treating a possible bacterial infection linked to the cancer. It is for adults newly diagnosed with early-stage lymphoma only in the eye area who have not had recent an…

This study is for adults with a rare, slow-growing blood cancer called splenic marginal zone lymphoma (SMZL) who have not yet had treatment. It aims to see if taking two drugs together (rituximab and zanubrutinib) is more effective at controlling the cancer and preventing it from…

This study looks back at existing medical scans from nearly 500 people with marginal zone lymphoma. Researchers want to understand how well PET scans work for determining the stage of the disease and predicting how patients will do after treatment. No new tests or treatments are …